Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 111, Issue 7, 3507-3513, April 1, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow
Blood Okorie et al. 111: 3507

Supplemental materials for: Okorie et al

Files in this Data Supplement:

  • Figure S1. Evaluation of TF wash out (JPG, 98.9 KB) -
    Whole blood was perfused over TF titration arrays either with a 5-min 1% HSA buffer pre-rinse or with no rinsing. Column averages of fluorescent intensity of the GPIb staining (A) and fibrin(ogen) (B) are plotted against the TF surface concentration on a semi-logarithmic scale for each condition (○ = no rinsing, ● = 5 minute rinse). Data is average ± SEM (N = 30).





  • Figure S2. Effect of 100 fM TF on thrombin-antithrombin (TAT) generation or conversion of a fluorogenic thrombin substrate in well plate assay (no flow) (JPG, 174 KB) -
    Generation of TAT by 0, 100 fM, or 10 pM of relipidated TF in CTI-treated, recalicified citrated whole blood with time (A). No TAT was detectable over 5 min in the presence or absence of 100 fM TF (A; insert) while 10 pM TF produced abundant TAT within 3 min after addition. Fractional conversion of the fluorogenic substrate boc-VPR-MCA (10 µM) in CTI-treated, recalcified whole blood in the presence or absence of 100 fM TF demonstrated that no thrombin was detectable during the first 5 min (B), while 100 fM TF caused a detectable enhancement of clotting compared to untreated control (C) (n = 4). Method: To detect thrombin activity with time, we added the fluorogenic stubstrate 10 µM boc-VPR-MCA to every well and detected the fluorescence of the released aminomethycoumarin (AMC) with a Thermo Fluoroskan fluorimeter preheated to 37°C every well was read once per minute for 4 hr. After the 4 hours, 5 U thrombin/well was added and then the plate was read again once per min for 20 min to determine the maximal signal to calculate fractional conversion of the peptide substrate.13





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020